Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- Dermatitis: postmarketing
- Rash
- 17-hydroxyprogesterone
- 18F-FDG
- 2-hydroxysuccinaldehyde
- 4-AP
- 4-PBA
- 4-methylpyrazole
- 5-ASA
- Rash: postmarketing, common, 1% - 23%
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Rash: common, very common, 0% - 14.1%
- 5-fluorocytosine
- 6-mercaptopurine
- 68Ga
- 8-MOP
- A77 1726
- ACTH(1-39
- AMD3100
- APAs
- Almeta
- Anidulafungin
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU
- Dermatitis
- Rash: 2% - 11.7%
- BPTI
- Benicar-HCT
- Bivalirudin
- Buscopan
- CAS 1405-87-4
- CAS 76095-16-4
- CAS 76420-72-9
- CGP 19835A
- Cancidas
- Colimycin M
- D-cycloserine
- D-penicillamine
- DFMO
- Dermatitis
- Rash: 0% - 2.8%
- Diane-35
- EACA
- EDTA
- Enfuvirtide
- Eptifibatide
- Rash: very rare, postmarketing
- Estrofem
- FAMP
- FK463
- FdUrd
- Fe(III
- Forteo
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132
- Glat copolymer
- Dermatitis: infrequent
- Rash
- Goserelin
- Hoe 140
- Humalog
- ICI 182,780
- Rash: postmarketing, 7.3% - 8%
- Implanon
- Insulin
- K779
- Dermatitis: 1% - 8%
- Rash: 1% - 34%
- Kaluril
- L-Dmp
- LY146032
- Rash: postmarketing, common, 2.5% - 8.62%
- Lantus
- Leuprorelin
- Dermatitis: 5% - 8%
- Rash: postmarketing, 3%
- LiOH
- Lisinopril
- Rash: postmarketing, uncommon, 1% - 5%
- Locorten Vioform
- Lovaza
- Lutalyse
- MK-462
- Madopar
- Meropenem anhydrous
- Mersyndol
- Metrodin
- Rash: postmarketing, 2.67% - 3.33%
- MnDPDP
- N-acetylcysteine
- N-carbamylglutamate
- NSC 352122
- Nafarelin
- NovoLog
- Rash: very rare, uncommon
- NuvaRing
- Nuvocid
- Octreotide
- Oestrogen
- Optison
- Rash: postmarketing, rare
- Org 37462
- PCI-32765
- PGE1
- PGE2
- Paroven
- Photofrin
- Photofrin II
- Dermatitis: uncommon
- Rash: common
- Prednefrin
- Promacta
- Refludan
- Revasc
- Romidepsin
- Dermatitis: 0.98% - 26.5%
- S-benzoylmercaptoacetyltriglycine
- SU5416
- Saxagliptin
- SonoVue
- Stalevo 50
- Supremon
- T-A2-3
- TMC207
- TMC435
- TPGS
- TR-700
- Tadenan
- Timentin
- TlCl
- Triphasil
- Triptorelin
- Trisequens
- UDCA
- VACV
- Rash: postmarketing, uncommon, 1% - 14%
- Vallergan
- Vancocine
- Vitrum
- Westcort
- Zyprexa Relprevv
- abacavir
- Rash: very rare, common, 4.82% - 68%
- abacavir-lamivudine
- Rash: postmarketing, common
- abiraterone
- acamprosate
- acarbose
- acebutolol
- acenocoumarol
- acetaminophen
- acetohydroxamic acid
- acipimox
- acitretin
- Dermatitis: postmarketing
- Rash: postmarketing
- acyclovir
- Rash: postmarketing, common, 1.3% - 1.7%
- adapalene
- adefovir
- adefovir dipivoxil
- Rash: postmarketing, common
- adenosine
- afatinib
- Rash: very common, 0% - 90%
- albendazole
- alclometasone
- alendronate
- alfentanil
- alfuzosin
- Rash: postmarketing, uncommon
- aliskiren
- allopurinol
- almotriptan
- Dermatitis: rare
- Rash: infrequent
- alogliptin
- alosetron
- Dermatitis
- Rash: postmarketing
- alprazolam
- Dermatitis: 0.6% - 4%
- Rash: infrequent, 8.1% - 11%
- amantadine
- ambrisentan
- Rash: postmarketing, uncommon
- amcinonide
- amifostine
- amikacin
- amiloride
- aminoglutethimide
- aminophylline
- amiodarone
- amitriptyline
- amlodipine
- amlodipine besylate
- ammonium lactate
- amobarbital
- amoxapine
- amoxicillin
- Rash: postmarketing, common
- amphetamine
- amphotericin B
- ampicillin
- amprenavir
- Rash: very common, 2% - 20%
- amsacrine
- anagrelide
- anastrozole
- Rash: postmarketing, 5.73% - 12.5%
- anthracycline
- apixaban
- apraclonidine
- Dermatitis: postmarketing
- apremilast
- aprepitant
- argatroban
- arginine
- aripiprazole
- arsenic
- arsenic trioxide
- asenapine
- aspirin
- atazanavir
- Rash: postmarketing, common, 9% - 14%
- atenolol
- atomoxetine
- Dermatitis: 2% - 4%
- Rash: common, 2%
- atorvastatin
- Rash: postmarketing, 1.1% - 3.9%
- atosiban
- atovaquone
- atracurium
- atropine
- Dermatitis: rare
- Rash: rare
- auranofin
- Rash: postmarketing, 24% - 39%
- avanafil
- axitinib
- azathioprine
- azelaic acid
- azelastine
- azilsartan
- azilsartan medoxomil
- azithromycin
- Dermatitis: 2%
- Rash: postmarketing, 3.4% - 9.4%
- aztreonam
- baclofen
- balsalazide
- bazedoxifene
- beclomethasone
- beclomethasone dipropionate
- beclomethasone monopropionate
- belinostat
- benazepril
- benazeprilat
- bendamustine
- Dermatitis
- Rash: 2.1% - 7.84%
- bendrofluazide
- benzocaine
- benztropine
- benzyl alcohol
- bepotastine
- bepridil
- betahistine
- betamethasone dipropionate
- betamethasone valerate
- betaxolol
- Dermatitis: postmarketing
- Rash: postmarketing, 0% - 1.2%
- bexarotene
- Dermatitis
- Rash: very common, 0% - 78%
- bezafibrate
- bicalutamide
- bicarbonate
- bimatoprost
- bisoprolol
- Dermatitis
- Rash: very rare, postmarketing, rare
- bleomycin hydrochloride
- boceprevir
- Dermatitis: common
- Rash: very common, 5% - 19%
- bortezomib
- Dermatitis
- Rash: 0% - 27.7%
- bosentan
- Dermatitis: uncommon
- Rash: postmarketing, uncommon
- bosutinib
- brimonidine
- Dermatitis: 0.302% - 0.909%
- Rash: postmarketing
- brinzolamide
- Dermatitis
- Rash: postmarketing
- bromazepam
- bromcresol green
- bromhexine
- bromocriptine
- budesonide
- Rash: postmarketing, 1% - 4.1%
- Dermatitis: postmarketing
- bumetanide
- buprenorphine
- bupropion
- Rash: postmarketing, frequent, 0.8% - 8%
- buspirone
- busulfan
- butabarbital
- butorphanol
- cabergoline
- cabozantinib
- caffeine
- calcipotriol
- canagliflozin
- candesartan
- candesartan cilexetil
- capecitabine
- Dermatitis: 1% - 37%
- Rash: 6% - 8%
- capreomycin
- captopril
- carbamazepine
- Rash: rare, very common, 7% - 13%
- carbenicillin
- carbidopa
- carbimazole
- carboplatin
- carboprost
- carnitine
- carvedilol
- cefaclor
- cefadroxil
- cefazolin
- cefdinir
- cefditoren
- cefepime
- cefixime
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil
- ceftaroline
- ceftazidime
- ceftizoxime
- ceftobiprole
- ceftriaxone
- Dermatitis
- Rash: postmarketing, 1.3% - 1.7%
- cefuroxime
- cefuroxime axetil
- celecoxib
- Dermatitis
- Rash: 1.2% - 2.2%
- celiprolol
- cephalexin
- cephem
- cerivastatin
- cetirizine
- Dermatitis
- Rash: postmarketing
- cetrorelix
- cevimeline
- chloramphenicol
- chloride
- chlorthalidone
- chlorzoxazone
- choline theophyllinate
- ciclesonide
- ciclopirox
- cidofovir
- Dermatitis: postmarketing
- Rash: postmarketing, very common, 29.6%
- cilazapril
- Dermatitis
- Rash: postmarketing
- cilostazol
- cimetidine
- cinacalcet
- Rash: postmarketing, common
- cinoxacin
- ciprofloxacin
- Dermatitis: rare
- Rash: postmarketing, rare, uncommon, 1% - 1.8%
- cisatracurium
- cisplatin
- citalopram
- Dermatitis: postmarketing, rare, infrequent, uncommon
- Rash: infrequent, uncommon, frequent, 1%
- cladribine
- Rash: very common, 10% - 27%
- clarithromycin
- Rash: postmarketing, common, 2.2% - 3%
- clindamycin
- Dermatitis: 0% - 1.19%
- Rash: postmarketing, 7%
- clindamycin phosphate
- clobazam
- Rash: postmarketing, 1.4%
- clobetasol
- Dermatitis
- Rash: postmarketing
- Dermatitis perioral
- clobetasol propionate
- Dermatitis
- Dermatitis perioral
- clobetasone butyrate
- clocortolone
- clodronate
- clofarabine
- clofazimine
- clomiphene citrate
- clomipramine
- Dermatitis: 2%
- Rash: rare, common, 4% - 8%
- clonazepam
- clonidine
- clopidogrel
- clorazepate
- clotrimazole
- clozapine
- cobicistat
- codeine
- colchicine
- Dermatitis
- Rash: postmarketing
- colesevelam
- colestimide
- colestipol
- colestyramine
- conjugated estrogens
- copolymer 1
- cortisol
- Dermatitis: 1.44% - 13.8%
- Rash: postmarketing
- Dermatitis perioral
- cosyntropin
- crizotinib
- crotamiton
- cyanocobalamin
- cyclobenzaprine
- cyclopentolate
- cyclophosphamide
- Dermatitis: postmarketing
- Rash
- cyproheptadine
- cyproterone
- cyproterone acetate
- Rash: very rare, rare, uncommon
- cysteamine
- cytarabine
- d-telaprevir
- dabigatran
- dabigatran etexilate
- dabrafenib
- Rash: very common, 0% - 53%
- dacarbazine
- dalbavancin
- dalteparin
- danazol
- dantrolene
- dapagliflozin
- darifenacin
- darunavir
- Dermatitis
- Rash: 5% - 19%
- dasatinib
- Dermatitis
- Rash: 0% - 21%
- deferasirox
- Rash: common, 1.54% - 13.2%
- deferiprone
- degarelix
- delamanid
- delavirdine
- Dermatitis
- Rash: 0% - 35.4%
- delta 9-THC
- demeclocycline
- demethyl
- deprenyl
- desipramine
- desloratadine
- desmopressin
- desogestrel
- desonide
- desoximetasone
- desvenlafaxine
- dexamethasone
- Rash
- Dermatitis
- Dermatitis perioral
- dexmedetomidine
- dexpanthenol
- dextrorphan
- diatrizoate
- diazepam
- diazoxide
- diclofenac
- Dermatitis: 1% - 2%
- Rash: postmarketing, infrequent, common, 0% - 46%
- dicloxacillin
- dicyclomine
- didanosine
- diethylenetriaminepentaacetic acid
- diethylpropion
- diflorasone diacetate
- diflunisal
- digoxin
- dihydrocodeine
- dihydroergotamine
- Rash: postmarketing, infrequent
- diltiazem
- Dermatitis
- Rash: postmarketing, 0% - 2.04%
- dimenhydrinate
- dimercaptosuccinic acid
- dipyridamole
- disopyramide
- docetaxel
- Dermatitis: 1% - 9%
- Rash: 0% - 25.9%
- dofetilide
- dolasetron
- dolutegravir
- domperidone
- donepezil
- Dermatitis: infrequent
- Rash: postmarketing, frequent
- doripenem
- dorzolamide
- dothiepin
- doxazosin
- Dermatitis: 1.3%
- Rash: postmarketing, 1% - 1.7%
- doxepin
- Dermatitis: rare
- Rash: rare
- doxorubicin
- Dermatitis
- Rash: postmarketing, common, very common, 0% - 28.5%
- doxycycline
- Rash: postmarketing, 3.76%
- doxycycline calcium
- doxycycline hyclate
- dronedarone
- droperidol
- duloxetine
- Rash: postmarketing, rare, frequent, 4%
- dutasteride
- efavirenz
- Dermatitis
- Rash: very common, 0% - 46%
- eletriptan
- eliglustat
- eltrombopag
- elvitegravir
- emedastine
- emtricitabine
- Rash: postmarketing, common, 9% - 21%
- entacapone
- entecavir
- Rash: postmarketing, uncommon
- ephedrine
- eplerenone
- eprosartan
- eribulin
- erlotinib
- ertapenem
- Dermatitis: 0% - 1%
- Rash: 1% - 8.3%
- erythromycin lactobionate
- eslicarbazepine
- eslicarbazepine acetate
- esomeprazole magnesium
- estazolam
- estradiol
- Dermatitis
- Rash: postmarketing, common, 2.87% - 8.89%
- estradiol cypionate
- estradiol valerate
- estramustine
- estramustine phosphate
- estrone
- ethacrynic acid
- ethambutol
- ethionamide
- ethosuximide
- ethotoin
- etidronate
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib
- Dermatitis
- Rash: postmarketing
- etravirine
- everolimus
- Rash: common, very common, 0% - 59%
- exemestane
- Dermatitis: 8.2%
- Rash: common, 0% - 2-5%
- ezetimibe
- famciclovir
- Rash: very rare, postmarketing, common, 0% - 3.3%
- famotidine
- febuxostat
- Dermatitis
- Rash: 0.5% - 1.6%
- felbamate
- felodipine
- fenofibrate
- Rash: uncommon, 1.5% - 2.31%
- fenoprofen
- fentanyl
- Dermatitis
- Rash: very rare, postmarketing, common, 0% - 8%
- ferumoxytol
- Rash: postmarketing, 0.4% - 1%
- fesoterodine
- fexofenadine
- fidaxomicin
- finasteride
- Rash: postmarketing, 0.5%
- flecainide
- flucloxacillin
- fluconazole
- fludarabine
- flumazenil
- flumethasone
- flunisolide
- flunitrazepam
- fluocinolone
- fluocinolone acetonide
- fluocinonide
- Rash: postmarketing
- Dermatitis perioral
- fluorescein
- Dermatitis: postmarketing
- Rash: postmarketing
- fluorometholone
- fluoxetine
- flurandrenolone
- flurazepam
- flurbiprofen
- flutamide
- fluticasone
- Dermatitis: postmarketing
- Rash: postmarketing, 0.452% - 1.38%
- Dermatitis perioral
- fluticasone furoate
- fluticasone propionate
- Rash: very rare, postmarketing, 0.2% - 1%
- Dermatitis perioral
- fluvastatin
- Dermatitis: postmarketing
- Rash: postmarketing, rare, 0.2% - 1.9%
- fluvoxamine
- Rash: infrequent, uncommon
- folate
- fondaparinux
- Rash: uncommon, 7.5% - 8.32%
- formoterol
- Rash: postmarketing, rare, 1.1% - 4%
- fosamprenavir
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- Dermatitis
- Rash: 1% - 1.4%
- fosinoprilat
- fosphenytoin
- furosemide
- fusidic acid
- gabapentin
- Rash: postmarketing, 0.9% - 1.5%
- gadobenate dimeglumine
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium
- gadopentetate
- gadoteridol
- gadoversetamide
- galantamine
- ganciclovir
- gatifloxacin
- gefitinib
- Dermatitis
- Rash: very common, 0% - 68.9%
- gemcitabine
- gemfibrozil
- Dermatitis: 0.6%
- Rash: 1.3% - 2.5%
- gemifloxacin
- Dermatitis
- Rash: postmarketing, 0.3% - 2.8%
- gentamicin
- glibenclamide
- gliclazide
- Dermatitis: 1.2% - 1.6%
- Rash: 1% - 1.2%
- glimepiride
- glipizide
- glutamine
- glycerol phenylbutyrate
- glycopyrrolate
- gold sodium thiomalate
- granisetron
- griseofulvin
- guaifenesin
- guanfacine
- Dermatitis: postmarketing
- Rash: postmarketing
- guanidinium
- halcinonide
- halobetasol
- halofantrine
- haloperidol
- Rash: very rare, postmarketing
- hepatitis B vaccines
- hetastarch
- hexachlorophene
- histamine
- homatropine
- hydralazine
- hydrochlorothiazide
- hydrocodone
- hydrocortisone butyrate
- hydroflumethiazide
- hydromorphone
- hydroxocobalamin
- hydroxybutyrate
- hydroxychloroquine
- hydroxyurea
- Dermatitis
- Rash: uncommon
- hydroxyzine
- ibandronate
- Dermatitis
- Rash: postmarketing, 1.3% - 3%
- ibuprofen
- icodextrin
- Dermatitis: postmarketing
- Rash: postmarketing, 5% - 10%
- idarubicin
- ifosfamide
- Dermatitis: 1%
- Rash: postmarketing
- iloperidone
- iloprost
- imatinib
- Dermatitis: very common, 1.5% - 38.9%
- Rash: very common, 0% - 53%
- imipramine
- imiquimod
- Dermatitis: uncommon, 0.2% - 0.5%
- Rash: uncommon, 0.1% - 1.1%
- indacaterol
- Rash: postmarketing, uncommon
- indapamide
- indinavir
- Dermatitis
- Rash: postmarketing, 1.2% - 19.1%
- indomethacin
- insulin detemir
- iodide
- iodixanol
- iohexol
- iopamidol
- iopromide
- ioversol
- ioxilan
- ipratropium bromide
- Rash: postmarketing, uncommon
- irbesartan
- Dermatitis: rare
- Rash: postmarketing, 1.3%
- irbesartan-hydrochlorothiazide
- irinotecan
- iron sucrose
- isoflurane
- isomannide
- isosorbide dinitrate
- isosorbide-5-mononitrate
- isoxsuprine
- isradipine
- itraconazole
- Rash: postmarketing, 1% - 9%
- ivabradine
- ivacaftor
- ivermectin
- ixabepilone
- kanamycin
- ketamine
- ketoconazole
- Dermatitis
- Rash: postmarketing
- ketoprofen
- ketorolac
- ketorolac tromethamine
- ketotifen
- labetalol
- lacosamide
- lactate
- lamivudine
- Rash: postmarketing, common, 1% - 14%
- lamotrigine
- lansoprazole
- Rash: 1.15% - 3.23%
- Dermatitis
- lapatinib
- Dermatitis: very common
- Rash: very common, 0% - 24%
- latanoprost
- leflunomide
- Rash: postmarketing, common, 7% - 12%
- lenalidomide
- Rash: postmarketing, uncommon, very common, 1.49% - 37.8%
- lercanidipine
- Dermatitis
- Rash: rare, common
- letrozole
- leucovorin
- Dermatitis: 1% - 25%
- Rash: postmarketing
- leuprorelin acetate
- Dermatitis: 16.9% - 19.7%
- Rash
- levetiracetam
- levocabastine
- levodopa/carbidopa
- levonorgestrel
- Dermatitis
- Rash: postmarketing
- lidocaine
- linaclotide
- linagliptin
- lincomycin
- lindane
- Dermatitis: postmarketing
- linezolid
- Dermatitis
- Rash: 0.4% - 15.2%
- liraglutide
- lisdexamfetamine dimesylate
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lomefloxacin
- loperamide
- loratadine
- lorazepam
- lorcaserin
- lormetazepam
- losartan
- lovastatin
- loxapine
- lubiprostone
- lurasidone
- mafenide acetate
- malvidin
- mannitol
- maprotiline
- maraviroc
- Dermatitis: 3.1%
- Rash: 5% - 11%
- mebendazole
- mebeverine
- mebrofenin
- medroxyprogesterone
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine
- megestrol
- megestrol acetate
- melatonin
- meloxicam
- Dermatitis
- Rash: 0% - 3.8%
- melphalan
- memantine
- Dermatitis: infrequent
- Rash: postmarketing, frequent
- meperidine
- mephenytoin
- meprobamate
- meropenem
- mesna
- metaiodobenzylguanidine
- metaxalone
- metformin
- Dermatitis: very rare, common
- Rash: very rare, common
- methadone
- methazolamide
- methenamine hippurate
- methenamine silver
- methimazole
- methocarbamol
- methotrexate
- methsuximide
- methyclothiazide
- methyl aminolevulinate
- methyldopa
- methylene blue
- methylene diphosphonate
- methylergometrine
- methylphenidate
- Dermatitis: postmarketing
- Rash: postmarketing, common, 1.3% - 2%
- methylprednisolone
- Dermatitis
- Rash
- Dermatitis perioral
- methylprednisolone sodium succinate
- methysergide
- metipranolol
- metoclopramide
- metolazone
- metoprolol
- Rash: rare, uncommon, common
- metronidazole
- Rash: very rare, postmarketing, 1%
- mexiletine
- mianserin
- miconazole
- midazolam
- midodrine
- mifepristone
- miglitol
- milnacipran
- milrinone
- minocycline
- Dermatitis
- Rash: 0% - 1.2%
- minoxidil
- mirabegron
- mirtazapine
- Rash: postmarketing, frequent
- misoprostol
- Dermatitis: postmarketing
- Rash: postmarketing
- mitomycin C
- mitotane
- mitoxantrone
- mivacurium
- moclobemide
- modafinil
- Rash: postmarketing, 1% - 4%
- moexiprilat
- molindone
- mometasone
- Rash: postmarketing
- Dermatitis perioral
- mometasone furoate
- Dermatitis
- Dermatitis perioral
- monomethylfumarate
- montelukast
- Dermatitis
- Rash: postmarketing, 1.6%
- morphine
- moxifloxacin
- moxonidine
- mupirocin
- mycophenolate mofetil
- mycophenolic acid
- Rash: postmarketing, 18% - 22.1%
- n-3 PUFA
- nabilone
- nabumetone
- nadolol
- nafcillin
- naftifine
- Rash: postmarketing, 0.5%
- nalbuphine
- nalidixic acid
- naltrexone
- nandrolone decanoate
- naproxen
- naratriptan
- Dermatitis: rare
- Rash: rare, infrequent
- nateglinide
- nebivolol
- Rash: postmarketing, 0% - 1%
- nedocromil sodium
- nefazodone
- nelfinavir
- Dermatitis
- Rash: postmarketing, common, 0% - 8%
- neostigmine
- nesiritide
- Rash: postmarketing, 0% - 1%
- nevirapine
- Rash: postmarketing, very common, 4% - 24%
- niacin
- nicardipine
- nicorandil
- nicotine
- nifedipine
- nilotinib
- Dermatitis: common
- Rash: 0% - 37%
- nilutamide
- nimodipine
- nisoldipine
- nitazoxanide
- nitrazepam
- nitrogen mustard
- Dermatitis: 17% - 58%
- Rash
- nitroglycerin
- nitroprusside
- nizatidine
- norethisterone
- norfloxacin
- nortriptyline
- nystatin
- ofatumumab
- ofloxacin
- ogen
- olanzapine
- Rash: postmarketing, rare, 2%
- olmesartan
- Rash: postmarketing, uncommon
- olmesartan medoxomil
- olodaterol
- olopatadine
- Dermatitis
- Rash: 0% - 1.34%
- olsalazine
- omeprazole
- Dermatitis: postmarketing, uncommon
- Rash: postmarketing, uncommon, 0% - 1.5%
- ondansetron
- orlistat
- Rash: postmarketing, uncommon, 4.3%
- oseltamivir
- Dermatitis: postmarketing, 1% - 5%
- Rash: postmarketing
- oxacillin
- oxaliplatin
- Rash: common, very common, 0% - 5%
- oxaprozin
- oxazepam
- oxcarbazepine
- Rash: very rare, postmarketing, common, 1.4% - 5.3%
- oxiconazole
- oxybutynin
- Dermatitis
- Rash: postmarketing
- oxycodone
- oxymorphone
- oxytetracycline
- oxytocin injection
- paclitaxel
- Dermatitis
- Rash: postmarketing, rare, very common, 9% - 14%
- paliperidone
- palonosetron
- pamidronate
- Rash: postmarketing, common
- pancuronium
- pantoprazole
- Rash: postmarketing, uncommon, 0% - 2%
- papaverine
- paraldehyde
- parecoxib
- paricalcitol
- Rash: postmarketing, 3.7% - 4%
- paroxetine
- Rash: postmarketing, uncommon, common, frequent
- pazopanib
- pegaptanib
- pemetrexed
- penciclovir
- penicillin
- pentamidine
- pentazocine
- pentobarbital
- pentosan polysulfate
- pentostatin
- pentoxifylline
- pergolide
- perhexiline
- perindopril
- perindopril erbumine
- Dermatitis
- Rash: postmarketing
- perindoprilat
- permethrin
- phenelzine
- phenobarbital
- phentermine
- phenylazo
- phenylbutyric acid
- phenyllactate
- phenylpropanolamine
- phenytoin
- Dermatitis
- Rash: frequent
- phosphate
- pilocarpine
- pimecrolimus
- Rash: postmarketing, rare
- pimozide
- Rash: postmarketing, 2.78% - 8.33%
- pindolol
- piperacillin
- pirbuterol
- Dermatitis
- Rash: 0% - 1.3%
- pirfenidone
- piroxicam
- pitavastatin
- podophyllotoxin
- polyoxyethylene
- polythiazide
- pomalidomide
- ponatinib
- posaconazole
- Dermatitis
- Rash: 1.72% - 15.1%
- Dermatitis flare-up
- potassium
- pralatrexate
- pramipexole
- Dermatitis
- Rash: uncommon
- prasugrel
- pravastatin
- Dermatitis: 7.2%
- Rash: 1.3% - 7.2%
- praziquantel
- prazosin
- prednicarbate
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin
- primidone
- probenecid
- procaine penicillin
- procarbazine
- prochlorperazine
- progesterone
- proguanil
- promethazine
- propafenone
- Dermatitis
- Rash: postmarketing, 0.6% - 3%
- propantheline
- propericiazine
- propofol
- propoxyphene
- propoxyphene napsylate
- propranolol
- propylthiouracil
- prostacyclin
- protriptyline
- pyrantel
- pyrazinamide
- pyridostigmine
- quetiapine
- Dermatitis: rare
- Rash: 4%
- quinapril
- quinaprilat
- quinidine
- Rash: 5% - 11%
- Dermatitis
- rabeprazole
- raloxifene
- raltegravir
- Dermatitis
- Rash: postmarketing
- raltitrexed
- ramipril
- ramiprilat
- ranitidine
- ranolazine
- rapamycin
- rasagiline
- Dermatitis: common
- Rash: common, 3% - 6%
- rasburicase
- reboxetine
- regadenoson
- regorafenib
- remifentanil
- repaglinide
- rescinnamine
- reserpine
- retigabine
- retinoic acid
- Dermatitis: postmarketing, very common, 3.8% - 55%
- Rash: postmarketing, very common, 1% - 54%
- Dermatitis perioral
- ribavirin
- Dermatitis: common, 13%
- Rash: very common, 5% - 34%
- rifabutin
- rifampicin
- rifapentine
- rifaximin
- rilpivirine
- riluzole
- rimantadine
- rimonabant
- risedronate
- risperidone
- Dermatitis: infrequent
- Rash: frequent, 0% - 11%
- ritonavir
- rivaroxaban
- rivastigmine
- Dermatitis: infrequent
- Rash: postmarketing, rare, infrequent, frequent
- rizatriptan
- rocuronium
- rofecoxib
- roflumilast
- ropinirole
- Dermatitis: infrequent, frequent
- Rash: postmarketing, infrequent, frequent
- ropivacaine
- rosiglitazone
- Rash: very rare, postmarketing
- rosuvastatin
- rotigotine
- roxithromycin
- rufinamide
- salbutamol
- Rash: postmarketing, 0% - 7.5%
- salicylate
- salmeterol
- salmon calcitonin acetate
- Dermatitis: postmarketing
- Rash: postmarketing
- salsalate
- samarium
- saquinavir
- scopolamine
- secobarbital
- sertraline
- Dermatitis: postmarketing, rare
- Rash: postmarketing, common, 3%
- sevelamer
- sevelamer carbonate
- sevelamer hydrochloride
- sevoflurane
- sibutramine
- sildenafil
- Rash: postmarketing, uncommon, 1% - 2%
- silodosin
- silver nanoparticles
- silver sulfadiazine
- simvastatin
- sitagliptin
- sitaxsentan
- sodium
- sodium cromoglycate
- sodium ferric gluconate
- sodium iodide
- sodium nitroprusside
- sofosbuvir
- Rash: very common, 8% - 18%
- solifenacin
- sorafenib
- Rash: postmarketing, 0% - 40%
- sotalol
- sparfloxacin
- spironolactone
- stavudine
- stiripentol
- streptomycin
- strontium ranelate
- Dermatitis
- Rash: postmarketing
- succinylcholine
- sufentanil
- sulfadiazine
- sulfamethoxazole
- sulfasalazine
- sulindac
- sumatriptan
- Rash: postmarketing, infrequent
- sunitinib
- tacrolimus
- Dermatitis: uncommon
- Rash: common, 1% - 24%
- tadalafil
- tamoxifen
- Rash: postmarketing, 13% - 12.5%
- tamsulosin
- Rash: postmarketing, uncommon, 1.8%
- tapentadol
- tazarotene
- technetium-99m
- tegaserod
- telavancin
- telithromycin
- telmisartan
- Dermatitis
- Rash: postmarketing, rare, uncommon, common
- temozolomide
- Dermatitis: common
- Rash: very rare, common, very common, 0% - 19.4%
- temsirolimus
- teniposide
- tenofovir
- Rash: postmarketing, 5% - 9%
- tenofovir disoproxil fumarate
- Rash: postmarketing, very common, 5% - 7%
- tenoxicam
- terazosin
- terbinafine
- terbutaline
- terconazole
- tesamorelin
- testosterone
- Rash: postmarketing, uncommon, common, 2%
- testosterone enanthate
- testosterone propionate
- testosterone undecanoate
- tetracycline
- tetraen
- tetrahydrobiopterin
- Rash: postmarketing, 5.41%
- tetrofosmin
- thalidomide
- theophylline
- thiabendazole
- thiazide
- thioridazine
- thiotepa
- thiothixene
- thymidine
- thyroxine
- tiagabine
- tiaprofenic acid
- tibolone
- ticagrelor
- ticlopidine
- tigecycline
- Rash: common, 2.4% - 4.1%
- timolol
- tinidazole
- tiopronin
- tiotropium
- tipranavir
- Rash: uncommon, common, 3.8% - 5.5%
- tizanidine
- Rash: postmarketing, frequent
- tobramycin
- Dermatitis: uncommon
- Rash: rare, common, 2.3% - 5.4%
- tofacitinib
- tolcapone
- topiramate
- Dermatitis: 0% - 7%
- Rash: very rare, postmarketing, 0.4% - 6.7%
- topotecan
- Dermatitis: postmarketing
- Rash: common, 0% - 16%
- torasemide
- toremifene
- trabectedin
- tramadol
- Dermatitis: postmarketing, uncommon
- Rash: uncommon
- tramazoline
- trametinib
- trandolapril
- Rash: postmarketing, 0.4% - 1.2%
- trandolaprilat
- trans 4-cyclohexyl-L-proline
- tranylcypromine
- travoprost
- trazodone
- treprostinil
- triamcinolone
- Rash: postmarketing
- Dermatitis perioral
- triamcinolone acetonide
- Rash: postmarketing, 2.5%
- Dermatitis perioral
- triamterene
- triazolam
- trifluoperazine
- trihexyphenidyl
- trimethadione
- trimethoprim
- Rash: common, 1.3% - 6.1%
- trimethoprim-sulfamethoxazole
- trimetrexate
- trimipramine
- tropisetron
- trospium chloride
- trovafloxacin
- umeclidinium
- ustekinumab
- Rash: postmarketing, uncommon, common
- v 1784
- Dermatitis: postmarketing
- Rash: postmarketing, uncommon, common, 7% - 12%
- valdecoxib
- Dermatitis
- Rash: 0.5% - 1.5%
- valganciclovir
- valproate
- valrubicin
- valsartan
- Rash: very rare, 0.2% - 0.6%
- vandetanib
- Dermatitis
- Rash: 0.4% - 53%
- vardenafil
- varenicline
- Dermatitis: infrequent
- Rash: 1% - 3%
- vecuronium
- vemurafenib
- Rash: postmarketing, 0% - 52%
- venlafaxine
- verapamil
- Rash: postmarketing, 2.4%
- verteporfin
- vigabatrin
- vincristine
- vinflunine
- vinorelbine
- Dermatitis: postmarketing
- Rash: postmarketing, 5%
- vismodegib
- vorapaxar
- voriconazole
- Rash: common, very common, 0.524% - 6.63%
- warfarin
- x M22
- zafirlukast
- zalcitabine
- zaleplon
- zanamivir
- ziconotide
- zidovudine
- Rash: postmarketing, uncommon, 12% - 17%
- zidovudine/lamivudine
- zileuton
- ziprasidone
- Rash: postmarketing, uncommon, 1% - 4%
- zoledronic acid
- Dermatitis
- Rash: uncommon, 2% - 3%
- zolmitriptan
- zolpidem
- Dermatitis: rare
- Rash: postmarketing, rare, frequent, 1% - 2%
- zonisamide
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|